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Gap junctions and connexins are present in the immune system. In haematopoiesis, connexin 43, the most widely distributed gap junction
protein, appears to be a key player in the development of progenitor cells and their communication with stromal cells. Connexin 43 is
expressed by macrophages, neutrophils and mast cells. Lymphocytes also express connexin 43, and inhibition of gap junction channels in
these cells by using highly specific connexin mimetic reagents has profound effects on immunoglobulin secretion and synthesis of cytokines.
Lymphocytes and leukocytes also communicate directly in vitro with endothelial cells via gap junctions. Connexins are implicated in
inflammatory reactions in a range of tissues. Their involvement in atherosclerotic plaque formation in the vascular system is also a current
growth point in research, and could lead to the development of therapeutic interventions.
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Multicellular organisms are characterised by the opera-
tion of extensive direct intercellular communication net-
works that link and balance the metabolic and mechanical
activities of the individual functional units. Such networks
connecting and co-ordinating attached cells are found not
only in compact tissues and organs but also in the various
cell types of the immune system comprising the lymphoid
organs as well as peripheral lymphocytes migrating
through the blood and lymphatic networks (Fig. 1). Direct
intercellular communication and strong adhesion are
effected by gap junctions (see Evans and Martin for a
comprehensive review) [1]. The present article collates
information on the distribution and possible roles of gap
junctions and the channel building blocks, the connexins,
in the various branches of the immune system. Connexins,
the proteins assembled into gap junction channels, are
tetra-pass membrane proteins that oligomerise into hex-0005-2736/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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1 Tel.: +44-117-928-4139; fax: +44-117-928-3581.americ hemichannels called connexons [2]. These proteins
range in size from about 25 to 60 kDa with the main
amino acid sequence differences found in the variable-
length cytoplasmically oriented carboxyl tail. Over 20
different connexins have been identified in murine and
human tissues [1]. After the recruitment of hexameric
connexons to the plasma membrane, they carry out two
functional options.
In the first, they may operate as unapposed hemichan-
nels. In the second, they dock with partner connexons in
neighbouring cells, to form gap junctions that allow direct
transfer of molecules and ions up to approximately 1.2 kDa
between the cytoplasms of the co-operating cells. Connexins
have been detected by a variety of techniques in all
nucleated cells, excepting adult striated muscle and sperm.
In the present article, we review data demonstrating the
widespread distribution of connexins in the component parts
of immune system and outline and speculate on some
functional implications. We also discuss the evidence point-
ing to the probable roles of connexin-mediated intercellular
signalling by cells of the immune system in inflammation.
The distribution and likely roles of gap junctions in the
immune system have been addressed in previous reviews
[3–5].
Fig. 1. Diagramatic overview of the distribution of connexins in the immune system. The diagram shows the distribution of connexins in primary, secondary
lymphoid organs and the various permutations of connexin-mediated interactions that may operate between monocytes (M) and lymphocytes (L) and
endothelium cells of the vascular wall. Monocytes and lymphocytes cross the endothelial and may communicate with it and each other by gap junctions (double
barrel) and/or by release of ATP or NAD+ through connexin hemichannels (single barrel). In peripheral tissues, communication via gap junctions or
hemichannels by lymphocytes (L) or macrophages (Mf) with, for example, stromal cells or fibroblasts may also occur.
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operative behaviour of cells comprising the various bran-
ches of the immune system (Fig. 1), it is perhaps not
surprising that gap junctions and their connexin protein
building blocks have been identified in lymphoid tissues
and cells (Table 1). Complex homocellular and heterocel-
lular type cross-talk occurring between lymphocytes
involves multiple receptor– ligand complexes and ion
channels and these cellular interactions, for example, have
recently been conceptualised as comprising an immuno-
logical synapse [6–9]. Although there is presently no
direct evidence showing that connexins reside at such
immunological synapses, there is indirect evidence show-
ing that blockage of connexon channel interactions using
highly specific peptide reagents disrupts immunoglobulin
release and cytokine production by lymphocytes [10].
Furthermore, since cells may express multiple connexins
that are likely to be assembled into a permutation of homo/
heteromeric connexons, thus providing the basis for homo/
heterotypic communication [1,11], these properties can
equip cells to fulfil the basic requirements for the extensive
and complex cross-talk that characterises the operation of
cells in the immune system. Thus, in the various branches
of the immune system, connexins and their assembledchannels should be considered as components that may
complement the complex cascade of molecular interactions
that underpin, for example, the rolling of leukocytes on the
endothelial wall (Fig. 1), a process involving receptor–
ligand interactions that implicate selectins, integrins, sialo-
mucins, etc. [12].
Undoubtedly delaying the growing appreciation of func-
tional roles for connexins in the immune system has been
the paucity of morphological evidence for gap junctions in
lymphoid organs. This is despite functional evidence for
direct communication in cells populating the immune sys-
tem suggested by the low electrical resistance detected
between contacting cells, and especially the direct intercel-
lular transfer between lymphocytes and leukocytes of small
highly fluorescent probes.
Nevertheless, the low incidence of morphologically
recognised gap junctions and the failure by immunologists
to recognise and appreciate the consequences of specific
properties highly indicative of direct and rapid intercellu-
lar communication in cells of the immune system should
not exclude completely the operation of a system that is
widespread in almost all tissues and organ systems. It is
also worth pointing out at this stage that a connexin-
dependent mechanism of intercellular communication that
Table 1
Gap junction intercellular communication and connexin expression in cells
of the immune system






T lymphocytesa + + Cx43, Cx40 [59]
B lymphocytesa + + Cx43, Cx40 [59]
Bone marrow stromal
cells (BMSC)








+ + Cx43 [5,38]
Monocytes +  Cx43 [78]




+ + Cx43 [54]
Mast cells +  Cx43 [18]
Heterotypic interaction
T–B cellsa + + Cx43, Cx40 [59]
T cells–endothelium + + Cx43 [75,110]
T–TECb + + Cx43 [34]
B–FDC + + Cx43 [42,110]
Haematopoietic stem
cells–BMSC
+ + Cx43 [36,37,
112]
FDC–endothelium +  Cx43 [110]
PMN–endothelium + + Cx43 [54,100]
Monocytes–
endothelium
+  Cx43 [70,78]
Macrophages–
endothelium
+ + Cx43 [70,113]
Macrophages–smooth
muscle cells
+  Cx43 [70,78,
79,82]
Mast cells– fibroblast +  Cx43, Cx32 [18]
a Derived from peripheral blood and/or secondary lymphoid organs.
b Thymocytes.
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featuring unopposed connexin hemichannels in the plasma
membrane is now being studied in an increasing number
of mammalian cells (Fig. 1). This connexin-dependent
mechanism of intercellular communication does not ap-
pear to utilise morphologically identifiable gap junctions,
and features the release by cells of adenine nucleotides,
especially ATP, that induce calcium signalling in close
neighbours and implicating plasma membrane purinergic
receptors [13–16]. Also this mechanism appears to be
sensitive to cellular injury, e.g. in hypoxic conditions.
Although the precise mechanism of ATP liberation by
cells and the contribution of connexin hemichannels are
unclear, the probable involvement of connexin hemichan-
nels in this release process has been highlighted recently
by studies showing that short connexin mimetic peptides,
which correspond to amino acid sequences in the two
extracellular loops of connexin 43, inhibit the release of
ATP by cells induced either by photoliberation of intra-
cellular IP3 or by reducing extracellular calcium levels
[17–19]. The connexin mimetic peptides are well-studiedinhibitors that prevent Ca2 + wave propagation via hemi-
channels as well as gap junctional communication in
tracheal epithelial cells [20,21]. This variation suggests
that the inhibitory action of connexin mimetics on con-
nexin hemichannels and gap junctions may vary between
different tissues. Connexin hemichannels were predicted
to exist on the plasma membrane from gap junction
biosynthetic considerations [1,22,23], the penetration into
cells of small dyes and the blockage of this dye uptake by
cells by connexin antibodies [24] and from electrophysi-
ological approaches [25–28] using Xenopus oocytes
[29,30] and cells of the retina [31]. Their gating and
regulation are being studied [32]. The potential functional
importance of these unapposed connexin hemichannels is
increasingly being defined in several cell types and these
results clearly broaden the scope of intercellular commu-
nicative action by plasma membrane channels constructed
of connexin subunits.
1.1. Gap junctions and connexins during haematopoesis
Detailed characterisation of connexin expression has
been carried out in the haematopoetic system where stem
cells have the ability to renew themselves and give rise to
the nine or more types of circulating blood cells. Earlier
studies showed that connexins 30.3, 31, 31.1, 43, and 45
mRNA are expressed [33] but analysis of freshly isolated
bone marrow cells as well as studies in derived cell lines
concluded that connexin 43 was by far the major gap
junction protein expressed by the specialised microenvir-
onmental stromal cells as well as stem cells (Fig. 1) [33–
36]. The regulatory mechanisms operational during haema-
topoesis are complex [35]. Nevertheless, present evidence
strongly points to important roles for connexins and gap
junctions in effecting communication between haemato-
poetic stem cells and stromal cells [35,37]. The generation
of Cx43 knockout mice has allowed more definitive studies
that have further emphasised the critical role of this con-
nexin in the intercellular networks that operate during
haematopoiesis [33,35].
1.2. Gap junctions and connexins in lymphoid organs
T-cell lymphoid progenitors differentiate in the bone
marrow and then migrate into the thymus where tight
intercellular contact and adhesion with stromal cells con-
tribute to their maturation. The thymus, with its compact
meshwork of cells ensuring direct exchange of intercellular
information, provides the organ platform where T cell clones
differentiate to provide ultimately the peripheral repertoire
of circulating cells. Thymic epithelial cells and thymocytes
have been shown to form functional gap junction channels
in both homotypic and heterotypic modes [38,39]. Again,
these gap junctions are constructed exclusively of connexin
43, and many studies have shown that their function is
differentially modulated by a variety of soluble factors
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clones migrate from primary (thymic) to secondary (lymph
node) lymphoid organs where they maturate further and
differentiate upon antigen stimulation, a process that is
acutely dependent on direct cell-to-cell contact and co-
operation. In this crucial differentiation step, other antigen-
presenting cells and epithelial supporting cells play impor-
tant roles. [40,41]. Connexin 43 appears to be the sole
connexin expressed in lymphoid tissue (Fig. 1), and support-
ing its implication in antigen processing and presentation are
studies showing that connexin 43 mRNA and protein
expression are directly up-regulated by antigenic challenge
[42]. Such studies suggest that connexin 43 is highly likely
to participate in antigen processing and presentation.
Follicular dendritic cells are also key players in antigen
presentation in secondary lymphoid organs with evidence
from dye transfer studies for direct communication between
each other and with B-lymphocytes implicating connexins
[42]. It has been proposed that gap junctions contribute to
the development and metabolism of germinal centres by
controlling the growth follicular dendritic cells [43].
1.3. Gap junctions in the innate immune system
The innate immune system provides the first line of
defence against pathogen infection, and consists mainly of
phagocytic cells (neutrophils and macrophages) as well as
dendritic and natural killer cells that act in an integrated
fashion to eliminate infectious agents [44,45].
A number of studies have pointed to the presence of gap
junctions in contacting macrophages [46–48] and between
macrophages and intestinal epithelial cells [49], although
some of these studies are controversial [48]. Specifically,
electron microscopic analysis of bone marrow has shown
gap junction-like structures in contacting macrophages and
between macrophages and reticular cells, neutrophils, eosi-
nophils, monocytes and erythroblasts [50]. These studies
suggest a role for macrophages in haematopoesis. The
identification of connexin 43 as the constituent protein of
macrophage gap junctions has been confirmed [51–54].
Continuing studies have focussed on the regulation of these
gap junctions by a range of pro-inflammatory factors such as
cytokines as well as growth factors [51–53]. Connexins
have emerged as key proteins in polymorphonuclear neutro-
phil functions after these cells are activated by lipopolysac-
charide in vivo and in vitro [54]. Corroborative studies have
identified gap junctions at leukocyte–leukocyte and leuko-
cyte–endothelial cell contacting areas, and gap junctions are
implicated in their trans-endothelial migration and its mod-
ification under inflammatory conditions [42,51,54,55]. Both
connexins 43 and 40 have been detected in these cells [56].
Coupling/attachment of neutrophils to endothelium by gap
junctions is a time-dependent process that is modulated by
the cytokine tumour necrosis factor and is facilitated by
heterotypic cell adhesion involving a range of well-studied
adhesion molecules [56].Mast cells, located in mucosa and connective tissue,
account for less than 0.2% of leukocytes, and their
proliferation is dependent on direct interactions with T
lymphocytes although mastocytes in connective tissue
interact extensively with fibroblasts [18]. These cells are
major participants in allergic interactions and in providing
immunity to parasitic infections. Gap junctions connecting
mast cells and fibroblasts were shown by electron micros-
copy in a chick embryo model [19], and they appear to be
constructed of connexins 32 and 43. Such studies strength-
en the universal roles played by gap junctions in the
physiology of tissue microenvironments, but the effects
of reagents that inhibit and disrupt gap junctions in these
systems are awaited.
1.4. Connexins and communication in lymphocytes and
between lymphocytes and endothelial cells
The pioneering electrophysiological studies of Hulser
and Peters [57,58], demonstrating low intercellular resis-
tance properties indicative of the presence of gap junctions
linking attached lymphocytes, drew little attention for over
20 years. No doubt, this lack of recognition of a role for
connexins in lymphocyte signalling persisted because of the
perceived limited requirement for such a mechanism in cells
that spend much of their time migrating through the lym-
phatic and blood vessels. However, several lines of evi-
dence, accrued in many laboratories, have independently
corroborated these important early studies.
Peripheral T, B and NK lymphocytes purified from
healthy humans express connexin 43. Lymphocytes de-
rived from secondary organs express, in addition, relatively
low levels of Cx40 [59]. Flow cytometry approaches using
anti-peptide connexin antibodies that bind to the extracel-
lular loops confirmed that the connexins are located on the
cell surface (Fig. 2) [59]. These observations are also
highly suggestive of the presence of unapposed connexon
hemichannels on lymphocytes with independent alternative
communication functions such as the ATP-mediated prop-
agation of calcium waves [60–62]. Calcein, a gap junction
permeant fluorescent dye, was observed to transfer be-
tween contacting lymphocytes; importantly, this direct
transfer was inhibited by two categories of gap junction
inhibitors [59] and thus implying direct communication
across these junctions. 18-a-Glycyrrhetinic acid, a widely
used inhibitor of gap junctional communication, is likely to
enter cells and modify protein kinases that feature in the
regulation of connexin 43 [63,64] that is extensively
phosphorylated at multiple serine residues and a few
threonine residues on the cytoplasmic tail [65]. In contrast,
the connexin mimetic peptides that bind to two specific
amino acid regions on the extracellular loops of connexin
43 are unlikely to penetrate into cells, undoubtedly a
property accounting for their high specificity and the
absence of inhibition of cellular metabolism [66]. Con-
nexin mimetic peptides are thus emerging as useful tools
Fig. 2. Connexins 43 and 40 are expressed by cell extracts (A) and at the plasma membrane (B) of T, B and NK human lymphocytes. In A, lymphocytes were
treated with phytohaemagglutinin (PHA-L) (lanes 1, 3 and 5) and lipopolysaccharide (LPS) (lanes 2, 4 and 6) for 0, 6 and 12 h, respectively; cellular proteins
were separated by SDS-polyacrylamide gel electrophoresis; and connexin expression analysed by Western blotting using antibodies to connexins 43 or 40.
Note the increase in connexin expression following addition of the two polyclonal stimulators. In B, cell surface expression of connexins was studied by FACS
analysis by double labelling with T cell (anti-CD3), B cell (anti-CD19) and NK cell (anti-CD56) antibodies and a connexin antibody generated to the
extracellular loops of connexin 43 [59].
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system and in unravelling roles for connexon hemichannels
in cell–cell signalling [17,61,62]. The adoption of two
means of connexin-mediated Ca2 + signalling between cells
involving both hemichannels and gap junctions and the
variable contribution of each route to overall communica-
tion is also likely to be influenced by the partner cells and
the extracellular matrix as exemplified by the roles of
integrins in modulating gap junctional communication in
alveolar cells [21,67,68].
Connexin mimetic peptides have emerged as important
reagents in revealing roles for connexins as functional
players in lymphocytes. Exposure of lymphocytes for
10–50 h to GAP26 and GAP27, short peptides that
correspond to specific amino acid sequences in the extra-
cellular loops of connexin 43, markedly reduced the
production of immunoglobulins (Ig) G, M and A in mixed
cultures of human T and B lymphocytes [10] (Fig. 3). A
small degree of intercellular channel rectification was
observed in heterotypic and homotypic T and B cell
cultures suggesting a role for lymphocyte gap junctions
in the polarisation of the immune response [10]. Addition
to cell media of connexin mimetics also demonstrated
complex temporal inhibitory effects on the synthesis of
cytokines, but less so on IL-2 and especially IL-10 (Fig.
3). FACS analysis using extracellular loop antibodies to
connexin 43 of lymphocyte populations revealed differ-ences indicating that CD4+, CD8+ and CD19+ cells
displayed a characteristic surface patterns under mitogenic
stimulation [59].
Interaction between lymphocytes and endothelial cells is
a central feature of vascular physiology. Blood-borne
lymphocytes leave the circulation via specialised postca-
pillary vessels, the high endothelial venules (HEV) [12].
The active processes of adhesion and transmigration across
the endothelial cell layer are complex and involve a series
of time-dependent molecular mechanisms which guarantee
not only adhesion but also direct intercellular communica-
tion. Gap junctions are present in varying degrees of
complexity along the vascular tree [69], and connexin43
[55,70], connexin40 [71,72] and connexin37 [73,74] have
been found to be consistently expressed in the vascular
wall as determined by mRNA and protein analysis. Lym-
phocytes establish functional gap junction channels with
endothelial cells in vitro during active transendothelial
migration in a time-dependent manner; these studies were
reinforced by others showing that the process was
inhibited by connexin mimetic peptides (Fig. 4) [75].
1.5. Connexins as possible inflammatory response markers
Inflammation is a local or systemic response of a tissue
to infection and usually leads to structural or functional
damage. Although the overall inflammatory response is
Fig. 3. Gap junction inhibitors decrease production by mixtures of T and B lymphocytes of (A) various immunoglobulins and (B) cytokines. Panel A shows the
inhibition of IgG, IgM and IgA by connexin mimetic peptide GAP27 or 18-a-glycyrrhetinic acid (alpha-GA) over 60 h. Panel B shows the inhibition of IL-2
and IL-10 by GAP27 and 18-a-glycyrrhetinic acid over 72 h.
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uration are key components. Leukocytes gain access to
inflammation sites by interacting with parenchymal cells
and the extracellular matrix, and an important aspect of
their involvement in inflammation involves transmigration
across endothelium.
There is increasing evidence for the implication of
connexins, especially connexin 43 during inflammation.
Endothelial and smooth muscle cells express connexin 43
with endothelial cells also expressing connexin 37 [1].
Normally, mononuclear cells are rarely found in subendo-
thelial spaces but during tissue or local vascular inflamma-
tion, such as in atherosclerosis, there is a large increase in
monocyte and lymphocyte numbers that associate with the
vascular wall and permeate extensively into the subendo-
thelial spaces [76,77]. In vitro studies have shown that co-
culturing endothelial and smooth muscle cells resulted in
increased production of IL-1 and IL-6 transforming growth
factor, and, importantly in the present context, significantly
higher expression of connexin 43 [78]. Connexin 43
expression by leukocytes is also susceptible to LPS stim-
ulation and increased during ischaemia reperfusion injury
[54]. These observations combine to suggest a connexin
involvement in the overall inflammatory response in the
arterial wall. A range of supporting studies, carried out
mainly in vitro, have demonstrated that gap junction-medi-
ated communication operates as assessed by direct dye
transfer between peripherally derived monocytes and endo-
thelial and smooth muscle cells or between macrophagefoam cells [55,79]. Furthermore, lipid loading of mono-
cytes/macrophages markedly reduced gap junctional com-
munication [80]. Expression of connexin 43 is increased in
areas of vessel intimal thickening at atheromatous lesions
where foam cells aggregate [55,79]. However, a direct
functional role specifically for connexin 43 is still contro-
versial and difficult to establish unequivocally since other
connexins including connexins 30, 37, and 45 are identified
in these lesions [81]. Further supporting the role for
connexin 43 in the inflammatory response are recent studies
by Kwak et al. [82] who studied expression patterns of
connexins 37, 40 and 43 in low-density-lipoprotein-defi-
cient mice and in human atherosclerotic plaques where a
redistribution of these connexins in the arterial wall oc-
curred during the development of atheroma [82]. Analysis
of the progression of atheroma indicated that it was much
reduced in the aorta of low-density-lipoprotein-deficient
mice as compared to controls, and these mice exhibited
fewer fibrous caps. Furthermore, and of direct clinical
relevance, are results showing that statins, drugs that reduce
cholesterol synthesis by inhibition of HMG CoA reductase,
reduced connexin 43 expression by cultured endothelial
cells [83]. These diverse observations strongly indicate that
connexin 43 and therefore channels constructed of this
protein are implicated in inflammatory events leading to
atheroma.
Besides involvement in inflammatory events in the
cardiovascular system, connexin expression is modified in
inflammatory events in other organ systems. When inflam-
Fig. 4. Direct intercellular communication via gap junctions between lymphocytes and endothelial cells. (A) During transendothelial migration in an in vitro
assay, the transfer of calcein (a low molecular weight green fluorescent dye) from endothelial cells (E) to lymphocytes (L) was analysed over time by two
photon laser scanning microscopy. In B, the specificity of transfer by a connexin-mediated mechanism was determined by FACS analysis of the dye transfer
occurring in the trans-well migration system. Connexin mimetic peptide GAP27 inhibited calcein transfer between endothelial cells and lymphocytes; as a
control, GAP18 (a peptide incorporating a short amino acid sequence in the intracellular loop of connexin 43) was used [75].
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in kidneys of patients with glomerulitis, connexin expres-
sion increases in parallel with ICAM-1 and VCAM-1
[84,85]. Connexins and gap junctions were also modified
when damage occurred in the central and peripheral nervous
systems. In the central nervous system, connexins are
widely distributed with connexin expression varying during
development and in injury processes. In summary, neurons
express mainly connexins 32, 36 and 43, oligodendrocytes
express connexins 29, 32 and 47, and astrocytes express
connexins 26, 30 and 43 [86–90]. Leukocytes have been
implicated in cerebral ischemia [91], where a role for
connexins and especially connexin hemichannels in astro-
cytes has been investigated in stroke models [92]. In
peripheral nerves, connexin 43 is mainly associated with
perineural fibroblasts and Schwann cell cytoplasm [93–95],
and there is high expression of connexin 32 at reflexive gap
junctions in Schwann cells [96].
Connexin expression is modified in the inflammatory
response to peripheral nerve damage and this has been
investigated in mouse and rat models of sciatic nerve
damage [97–99]. After injury there are changes in con-
nexin 32 and 46 expression. Interestingly, there appears to
be a linkage between the down regulation of connexin 32
and up-regulation of connexin 43 in endoneural fibroblastsand infiltrating macrophages. It has been proposed that
many of these changes in various cell types are induced
by the release of inflammatory cytokines by endothelial
cells and transmigrating leukocytes [78,100]. The changes
in expression of connexins 32 and 43 appear to vary
according to the tissues examined. In liver, for example
after LPS induced inflammation, connexin 32 is rapidly
degraded [101–103], an event that coincides with a
decrease in cell communication ascertained by lowered
dye coupling [104].
Connexin 26 is one of the smallest connexins with a
short 16-amino-acid cytoplasmic tail (connexin 43 has a tail
of 156 amino acids). Connexin 26 is associated with
inflammation in the cochlea where cells of the stria vascu-
laris are connected by gap junctions. It has been suggested
that local release of proinflammatory cytokines such as
tumour necrosis factor alpha or interleukin 1 beta by
immune system cells may contribute to the lowering of
connexin 26 expression. This decrease in connexin 26 levels
in the ear contrasts with the lack of change in connexin 26
expression in liver following LPS treatment [104].
The above observations combine to indicate that acute
inflammation involving cells of the immune system can
trigger changes in the expression and probably the func-
tional involvement of gap junctions communication chan-
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leukocytes.
However, it is apparent that these changes monitored at
the protein or RNA levels are complex and vary between
various tissue/organ systems. However, one may generalise
and comment that changes in connexin 43 are mainly
associated with early inflammatory events involving mac-
rophage infiltration and endothelial cell activation. In
contrast, down-regulation of connexin 32 seems to point
to tissue damage and the consequential functional disrup-
tion. Various systems are thus likely to be affected in
different ways probably because of the presence of differ-
ent connexin expression profiles allowing channels linking
similar and dissimilar cells with varying selectivity to be
established.References
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